Improved rna editing method
AssigneeEdigene Therapeutics (Beijing) Inc.
InventorsPengfei YUAN, Zexuan YI, Nengyin LIU
Life of this patent
Estimating the term…
Loading patent…
AssigneeEdigene Therapeutics (Beijing) Inc.
InventorsPengfei YUAN, Zexuan YI, Nengyin LIU
Estimating the term…
Provided is a method for editing a target RNA at a target residue position of a host cell. The method comprises introducing ADAR-recruiting RNA (arRNA) or a construct encoding the arRNA into a host cell, wherein the arRNA comprises a complementary RNA sequence that hybridizes to a target RNA; the target residue is located in a three-base motif comprising a 5′ nearest-neighbor residue (upstream residue) of the target residue in the target RNA, the target residue, and a 3′ nearest-neighbor residue (downstream residue) of the target residue in the target RNA, wherein the three-base motif is not UAG, and the complementary RNA sequence comprises a mismatch directly opposite to the upstream residue or the downstream residue in the target RNA. Further provided are arRNA for the method, an RNA obtained by the method, a host cell comprising the RNA, and use of the method in the treatment of a disease.
A method for editing target RNA at a target residue position in a host cell, which comprises introducing ADAR-recruiting RNA (arRNA) or a construct encoding the arRNA into a host cell, wherein the arRNA comprises a complementary RNA sequence that hybridizes to a target RNA;
2-3. (canceled)
(canceled)
10-17. (canceled)
21-23. (canceled)
30-32. (canceled)
34-45. (canceled)
47-50. (canceled)
(canceled)
(canceled)
56-57. (canceled)
Dependencies are inferred from the claim text.